Who should own revolutionary gene editor CRISPR? Scientists or the public?

crispr

In a one sentence ruling, an appeals board granted the rights to the powerful gene editing technology CRISPR-Cas9 to the Broad Institute of Harvard and MIT, while leaving the door open for rival CRISPR pioneer UC Berkeley to file a new patent to lay claim to those same discoveries.

Why does this matter? While academic researchers can still use CRISPR for free, companies hoping to harness the gene editing tool to fight disease, solve agricultural problems, or for myriad other potential applications, may have to pay not one, but both institutions, a hefty fee. It’s a decision has caused some to some to wonder whether the rights to such revolutionary technology don’t really belong to a third party: the people.

[T]he non-profit group Knowledge Ecology International plans to file a request to the Department of Health and Human Services asking the federal government to step in and ensure that CRISPR remains accessible to anyone who wants to use it.

…

The group’s filing hinges on a 1980 law that says when research is funded by the federal government, as it was at both Berkeley and Broad, then the public can petition the government to “march-in” if patents are not being licensed on reasonable terms.

The petition is a long-shot. Since the law was enacted, the NIH…has never actually stepped in to officially intervene.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post: Should Anyone Own the Most Powerful Gene Editing Technology Ever Invented?

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-11-17-at-12.18.09-PM
Challenging glyphosate fear-mongering: Statewide Nebraska study finds no link between weedkiller use and non-Hodgkin lymphoma
Soybean Harvest in Cupped Hands
30 years of GMO farming: Defying cynics, we’ve had larger harvests, lower costs, and $385 billion in added global farmer income
Screenshot-2026-11-18-at-2.44.24-PM
Why should thousands of Americans die every year waiting for a kidney transplant? There’s an easy fix to this morbid reality
Health vs
Health vs. Hype’s rocky debut: American Medical Association’s misinformation-debunking podcast platforms ‘leaky gut’ wellness crank 
Low-Poly Climate Connections Infographic
Viewpoint: EU-backed climate “disinformation” crackdown—who polices what’s false?
measles
The grim human cost of the Trump—RFK Jr. measles-prevention failure: 16 times more cases than in 2024
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Gloved Hand Holding M-M-R Vaccine Vial
Viewpoint: The dangerous lie RFK Jr.-founded Children’s Health Defense is circulating to discredit one of medicine’s great breakthroughs: the MMR (measles-mumps-rubella) vaccine
BEMT Lotion for Freckled Skin
Burned by FDA bureaucracy: Why Americans waited decades for cancer-preventing sunscreen
Screenshot-2026-11-17-at-12.56.22-PM
RFK Jr.’s CDC blocked measles risk alert for pregnant women; 112 contracted the disease, and one-quarter were hospitalized
Screenshot-2026-11-17-at-11.04.14-AM
There are more than 6,000 genetic disorders. For the first time, gene editing is making some treatable. Are we ready?
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.